Sino Biological
- Total Funding$45.2 M
OverviewSuggest Edit
Sino Biological is a biotechnology company. It provides proteins, antibodies, cDNA/genes, transfection agents, cell lysates, and antibody purification agents for basic, translational, and clinical research to study cellular function and human diseases.
| Type | Private | |
| Founded | 2007 | |
| HQ | Chesterbrook, PA, US | Map |
| Website | sinobiological.com |
Recent NewsAll News
- Sino Biological and Ainnocence Partner to Offer Next-Generation CRO Antibody Development Services
- Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China
- Sino Biological Establishes New Location in Houston, Texas
- Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant
Latest Updates
| Employees (est.) (Aug 2022) | 114 | |
| Cybersecurity rating | C | More |
Key People/Management at Sino Biological
Liangzhi Xie
Chairman
Jie Zhang
General Manager
Sino Biological Office Locations
Sino Biological has offices in Chesterbrook and Eschborn
Chesterbrook, PA, US (HQ)
1400 Liberty Ridge Dr Suite 101
Eschborn, DE
Düsseldorfer Str. 40
Sino Biological Financials and Metrics
Summary Metrics
Founding Date | 2007 |
Sino Biological total Funding | $45.2 m |
Sino Biological latest funding size | $15.79 m |
Time since last funding | 4 years ago |
Sino Biological investors | Qiming Venture Partners |
Sino Biological's latest funding round in May 2018 was reported to be $15.8 m. In total, Sino Biological has raised $45.2 m
Sino Biological Cybersecurity Score
Sino Biological Online and Social Media Presence
3.84k Twitter followers
Sino Biological has 3.84k Twitter Followers. The number of followers has increased 3.9% month over month and increased 4.3% quarter over quarter
Sino Biological's Trends
Twitter Engagement Stats for @SinoInc
374
Tweets
379
Following
3.8k
Followers
18
Tweets last 30 days
0.2
Avg. likes per Tweet
66.7%
Tweets with engagement
Sino Biological News and Updates
March 28, 2022
Sino Biological and Ainnocence Partner to Offer Next-Generation CRO Antibody Development Services
Beijing, China, March 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contr…
March 15, 2022
Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China
Beijing, China, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical cont…
January 06, 2022
Sino Biological Establishes New Location in Houston, Texas
Houston, TX, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE:301047) that provides biological research reagents and related technical contract re…
December 07, 2021
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant
BEIJING, China, Dec. 7, 2021 /PRNewswire/ -- Sino Biological, Inc. (http://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus, which quickly raised concerns...
October 19, 2021
Sino Biological, Inc. to be Featured on Worldwide Business with kathy ireland
Beijing, China - (NewMediaWire) - October 19, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research services, will be featured on Worldwide Business with kathy ireland®, airi…
August 16, 2021
Sino Biological, Inc. Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange
Shenzhen, China, Aug. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen St…
Sino Biological Frequently Asked Questions
When was Sino Biological founded?
Sino Biological was founded in 2007.
Who are Sino Biological key executives?
Sino Biological's key executives are Liangzhi Xie and Jie Zhang.
How many employees does Sino Biological have?
Sino Biological has 114 employees.
Who are Sino Biological competitors?
Competitors of Sino Biological include Verogen, Vigene Biosciences and ViaCord.
Where is Sino Biological headquarters?
Sino Biological headquarters is located at 1400 Liberty Ridge Dr Suite 101, Chesterbrook.
Where are Sino Biological offices?
Sino Biological has offices in Chesterbrook and Eschborn.
How many offices does Sino Biological have?
Sino Biological has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies